Ficus deltoidea promotes bone formation in streptozotocin-induced diabetic rats

References

• Abdul-Majeed S, Mohamed N, Soelaiman IN. 2012. Effects of tocotrienol and lovastatin combination on osteoblast and osteoclast activity in estrogen-deficient osteoporosis. Evid Based Complement Alternat Med. 2012:960742.
   PubMed Web of Science ®Google Scholar
• Abuohashish HM, Al-Rejaie SS, Al-Hosaini KA, Parmar MY, Ahmed MM. 2013. Alleviating effects of morin against experimentally-induced diabetic osteopenia. Diabetol Metab Syndr. 5(1):5.
   PubMedGoogle Scholar
• Adeghate E, Kalász H. 2011. Amylin analogues in the treatment of diabetes mellitus: medicinal chemistry and structural basis of its function. Open Med Chem J. 5(Suppl 2):78–81.
   PubMedGoogle Scholar
• Ajami E, Mahno E, Mendes VC, Bell S, Moineddin R, Davies JE. 2014. Bone healing and the effect of implant surface topography on osteoconduction in hyperglycemia. Acta Biomater. 10(1):394–405.
   PubMed Web of Science ®Google Scholar
• Ashton JR, West JL, Badea CT. 2015. In vivo small animal micro-CT using nanoparticle contrast agents. Front Pharmacol. 6:256.
   PubMed Web of Science ®Google Scholar
• Ay B, Parolia K, Liddell RS, Qiu Y, Grasselli G, Cooper DML, Davies JE. 2020. Hyperglycemia compromises rat cortical bone by increasing osteocyte lacunar density and decreasing vascular canal volume. Commun Biol. 3(1):20.
   PubMed Web of Science ®Google Scholar
• Azmi NS, Hashim N, Samsulrizal N, Zin NSNM. 2019. The osteoprotective effect of Azadirachta excelsa leaves extract on bone of streptozotocin-induced diabetic rats. J Teknol. 81(5):129–137.
   Web of Science ®Google Scholar
• Bloomgarden ZT. 2009. Bone disease, gestational diabetes mellitus, and health care. Diabetes Care. 32(7):e77–e83.
   PubMedGoogle Scholar
• Bunawan H, Amin NM, Bunawan SN, Baharum SN, Mohd Noor N. 2014. Ficus deltoidea Jack: a review on its phytochemical and pharmacological importance. Evid Based Complement Alternat Med. 2014:902734.
   PubMed Web of Science ®Google Scholar
• Burghardt AJ, Link TM, Majumdar S. 2011. High-resolution computed tomography for clinical imaging of bone microarchitecture. Clin Orthop Relat Res. 469(8):2179–2193.
   PubMed Web of Science ®Google Scholar
• Che Ahmad Tantowi NA, Lau SF, Mohamed S. 2018. Ficus deltoidea prevented bone loss in preclinical osteoporosis/osteoarthritis model by suppressing inflammation. Calcif Tissue Int. 103(4):388–399.
   PubMed Web of Science ®Google Scholar
• Chen S, Liu D, He S, Yang L, Bao Q, Qin H, Liu H, Zhao Y, Zong Z. 2018. Differential effects of type 1 diabetes mellitus and subsequent osteoblastic β-catenin activation on trabecular and cortical bone in a mouse model. Exp Mol Med. 50(12):1–14.
   Google Scholar
• Cheung CL, Tan KC, Lam KS, Cheung BM. 2013. The relationship between glucose metabolism, metabolic syndrome, and bone-specific alkaline phosphatase: a structural equation modeling approach. J Clin Endocrinol Metab. 98(9):3856–3863.
   PubMed Web of Science ®Google Scholar
• Coe LM, Zhang J, McCabe LR. 2013. Both spontaneous Ins2(+/−) and streptozotocin-induced type I diabetes cause bone loss in young mice. J Cell Physiol. 228(4):689–695.
   PubMed Web of Science ®Google Scholar
• Dong Y, Jing T, Meng Q, Liu C, Hu S, Ma Y, Liu Y, Lu J, Cheng Y, Wang D, et al. 2014. Studies on the antidiabetic activities of Cordyceps militaris extract in diet-streptozotocin-induced diabetic Sprague-dawley rats. Biomed Res Int. 2014:160980.
   PubMed Web of Science ®Google Scholar
• Farsi E, Shafaei A, Hor SY, Ahamed MB, Yam MF, Asmawi MZ, Ismail Z. 2013. Genotoxicity and acute and subchronic toxicity studies of a standardized methanolic extract of Ficus deltoidea leaves. Clinics (Sao Paulo). 68(6):865–875.
   PubMed Web of Science ®Google Scholar
• Feng X, McDonald JM. 2011. Disorders of bone remodeling. Annu Rev Pathol. 6:121–145.
   PubMed Web of Science ®Google Scholar
• Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL. 2007. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J. 6(1):2.
   PubMedGoogle Scholar
• Gundberg CM, Lian JB, Booth SL. 2012. Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr. 3(2):149–157.
   PubMed Web of Science ®Google Scholar
• Guo JD, Li L, Shi YM, Wang HD, Hou SX. 2013. Hydrogen water consumption prevents osteopenia in ovariectomized rats. Br J Pharmacol. 168(6):1412–1420.
   PubMed Web of Science ®Google Scholar
• Guo CJ, Xie JJ, Hong RH, Pan HS, Zhang FG, Liang YM. 2019. Puerarin alleviates streptozotocin (STZ)-induced osteoporosis in rats through suppressing inflammation and apoptosis via HDAC1/HDAC3 signaling. Biomed Pharmacother. 115:108570.
   PubMed Web of Science ®Google Scholar
• Gurukar MSA, Mahadevamma S, Chilkunda ND. 2013. Renoprotective effect of Coccinia indica fruits and leaves in experimentally induced diabetic rats. J Med Food. 16(9):839–846.
   PubMed Web of Science ®Google Scholar
• Horcajada-Molteni M-N, Chanteranne B, Lebecque P, Davicco M-J, Coxam V, Young A, Barlet J-P. 2001. Amylin and bone metabolism in streptozotocin-induced diabetic rats. J Bone Miner Res. 16(5):958–965.
   PubMed Web of Science ®Google Scholar
• Huang Y, Dessel JV, Depypere M, EzEldeen M, Iliescu AA, Santos ED, Lambrichts I, Liang X, Jacobs R. 2014. Validating cone-beam computed tomography for peri-implant bone morphometric analysis. Bone Res. 2(1):14010.
   PubMedGoogle Scholar
• Hwang HS, Kim HA. 2015. Chondrocyte apoptosis in the pathogenesis of osteoarthritis. Int J Mol Sci. 16(11):26035–26054.
   PubMed Web of Science ®Google Scholar
• Kaddam IM, Iqbal SJ, Holland S, Wong M, Manning D. 1994. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone. Ann Clin Biochem. 31(4):327–330.
   PubMedGoogle Scholar
• Kalaitzoglou E, Fowlkes JL, Popescu I, Thrailkill KM. 2019. Diabetes pharmacotherapy and effects on the musculoskeletal system. Diabetes Metab Res Rev. 35(2):e3100.
   PubMed Web of Science ®Google Scholar
• King KB, Rosenthal AK. 2015. The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms. Osteoarthritis Cartilage. 23(6):841–850.
   PubMed Web of Science ®Google Scholar
• Kishimoto H, Akagi M, Zushi S, Teramura T, Onodera Y, Sawamura T, Hamanishi C. 2010. Induction of hypertrophic chondrocyte-like phenotypes by oxidized LDL in cultured bovine articular chondrocytes through increase in oxidative stress. Osteoarthritis Cartilage. 18(10):1284–1290.
   PubMed Web of Science ®Google Scholar
• Kumar A, Mittal S, Orito S, Ishitani K, Ohta H. 2010. Impact of dietary intake, education, and physical activity on bone mineral density among North Indian women. J Bone Miner Metab. 28(2):192–201.
   PubMed Web of Science ®Google Scholar
• Lee C, An D, Park J. 2016. Hyperglycemic memory in metabolism and cancer. Horm Mol Biol Clin Investig. 26(2):77–85.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Hong JY, Kim SC, Joo JK, Na YJ, Lee KS. 2015. The association between oxidative stress and bone mineral density according to menopausal status of Korean women. Obstet Gynecol Sci. 58(1):46–52.
   PubMedGoogle Scholar
• Lepetsos P, Papavassiliou AG. 2016. ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta. 1862(4):576–591.
   PubMed Web of Science ®Google Scholar
• Li P, Zhang L, Tian X, Xing J. 2014. Docosahexaenoic acid has an anti-diabetic effect in streptozotocin-induced diabetic mice. Int J Clin Exp Med. 7(9):3021–3029.
   PubMed Web of Science ®Google Scholar
• Logar DB, Komadina R, Prezelj J, Ostanek B, Trost Z, Marc J. 2007. Expression of bone resorption genes in osteoarthritis and in osteoporosis. J Bone Miner Metab. 25(4):219–225.
   PubMed Web of Science ®Google Scholar
• Longo AB, Ward WE. 2016. PUFAs, bone mineral density, and fragility fracture: findings from human studies. Adv Nutr. 7(2):299–312.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193(1):265–275.
   PubMed Web of Science ®Google Scholar
• Marin C, Luyten FP, der Schueren BV, Kerckhofs G, Vandamme K. 2018. The impact of type 2 diabetes on bone fracture healing. Front Endocrinol (Lausanne). 9:6.
   PubMed Web of Science ®Google Scholar
• Martins JB, Mendonça VA, Rocha EV, Tossige-Gomes R, Fonseca SF, Costa KB, Avelar NCP, Gomes WF, Lacerda ACR. 2015. Walking training decreases the plasma TBARS concentration in elderly women with knee osteoarthritis. Ann Sports Med Res. 2:1034.
   Google Scholar
• Motyl K, McCabe LR. 2009. Streptozotocin, type I diabetes severity and bone. Biol Proced Online. 11:296–315.
   PubMed Web of Science ®Google Scholar
• Nugroho RA, Aryani R, Manurung H, Rudianto R, Prahastika W, Juwita A, Alfarisi AK, Pusparini NAO, Lalong A. 2020. Acute and subchronic toxicity study of the ethanol extracts from Ficus deltoidea leaves in male mice. Open Access Maced J Med Sci. 8(A):76–83.
   Google Scholar
• Nurdiana S, Goh YM, Ahmad H, Dom SM, Syimal’ain Azmi N, Noor Mohamad Zin NS, Ebrahimi M. 2017. Changes in pancreatic histology, insulin secretion and oxidative status in diabetic rats following treatment with Ficus deltoidea and vitexin. BMC Complement Altern Med. 17(1):290.
   PubMedGoogle Scholar
• Nurdiana S, Goh YM, Hafandi A, Dom SM, Nur Syimal'ain A, Noor Syaffinaz NM, Ebrahimi M. 2018. Improvement of spatial learning and memory, cortical gyrification patterns and brain oxidative stress markers in diabetic rats treated with Ficus deltoidea leaf extract and vitexin. J Tradit Complement Med. 8(1):190–202.
   PubMedGoogle Scholar
• Onur T, Wu R, Metz L, Dang A. 2014. Characterisation of osteoarthritis in a small animal model of type 2 diabetes mellitus. Bone Joint Res. 3(6):203–211.
   PubMed Web of Science ®Google Scholar
• Osima M, Kral R, Borgen TT, Høgestøl IK, Joakimsen RM, Eriksen EF, Bjørnerem Å. Å. 2017. Women with type 2 diabetes mellitus have lower cortical porosity of the proximal femoral shaft using low-resolution CT than nondiabetic women, and increasing glucose is associated with reduced cortical porosity. Bone. 97:252–260.
   PubMed Web of Science ®Google Scholar
• Peng J, Hui K, Hao C, Peng Z, Gao QX, Jin Q, Lei G, Min J, Qi Z, Bo C, et al. 2016. Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice. Connect Tissue Res. 57(4):277–289.
   PubMed Web of Science ®Google Scholar
• Permuy M, Guede D, López-Peña M, Muñoz F, Caeiro JR, González-Cantalapiedra A. 2015. Effects of diacerein on cartilage and subchondral bone in early stages of osteoarthritis in a rabbit model. BMC Vet Res. 11:143.
   PubMed Web of Science ®Google Scholar
• Rao Sirasanagandla S, Ranganath Pai Karkala S, Potu BK, Bhat KM. 2014. Beneficial effect of Cissus quadrangularis Linn. on osteopenia associated with streptozotocin-induced type 1 diabetes mellitus in male wistar rats. Adv Pharmacol Sci. 2014:483051.
   PubMedGoogle Scholar
• Salleh N, Ahmad VN. 2013. In-vitro effect of Ficus deltoidea on the contraction of isolated rat's uteri is mediated via multiple receptors binding and is dependent on extracellular calcium. BMC Complement Altern Med. 13:359.
   PubMed Web of Science ®Google Scholar
• Song S-H, Zhai Y-K, Li C-Q, Yu Q, Lu Y, Zhang Y, Hua W-P, Wang Z-Z, Shang P. 2016. Effects of total flavonoids from Drynariae Rhizoma prevent bone loss in vivo and in vitro. Bone Rep. 5:262–273.
   PubMedGoogle Scholar
• Stalvey MS, Havasi V, Tuggle KL, Wang D, Birket S, Rowe SM, Sorscher EJ. 2017. Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat. PLoS One. 12(11):e0188497.
   PubMed Web of Science ®Google Scholar
• Starup-Linde J. 2013. Diabetes, biochemical markers of bone turnover, diabetes control, and bone. Front Endocrinol (Lausanne). 4:21.
   PubMedGoogle Scholar
• Sulaiman MR, Hussain MK, Zakaria ZA, Somchit MN, Moin S, Mohamad AS, Israf DA. 2008. Evaluation of the antinociceptive activity of Ficus deltoidea aqueous extract. Fitoterapia. 79(7-8):557–561.
   PubMed Web of Science ®Google Scholar
• Suthon S, Jaroenporn S, Charoenphandhu N, Suntornsaratoon P, Malaivijitnond S. 2016. Anti-osteoporotic effects of Pueraria candollei var. mirifica on bone mineral density and histomorphometry in estrogen-deficient rats. J Nat Med. 70(2):225–233.
   PubMed Web of Science ®Google Scholar
• Wakabayashi S, Sakurai T, Kashima I. 2004. Relationships between bone strength and bone quality: three-dimensional imaging analysis in ovariectomized mice. Oral Radiol. 20(1):32.
   Google Scholar
• Wongdee K, Charoenphandhu N. 2011. Osteoporosis in diabetes mellitus: possible cellular and molecular mechanisms. World J Diabetes. 2(3):41–48.
   PubMedGoogle Scholar
• Xie H, Wang Q, Zhang X, Wang T, Hu W, Manicum T, Chen H, Sun L. 2018. Possible therapeutic potential of berberine in the treatment of STZ plus HFD-induced diabetic osteoporosis. Biomed Pharmacother. 108:280–287.
   PubMed Web of Science ®Google Scholar
• Xu C, Zhu S, Wu M, Zhao Y, Han W, Yu Y. 2014. The therapeutic effect of rhMK on osteoarthritis in mice, induced by destabilization of the medial meniscus. Biol Pharm Bull. 37(11):1803–1810.
   PubMed Web of Science ®Google Scholar
• Yahara Y, Takemori H, Okada M, Kosai A, Yamashita A, Kobayashi T, Fujita K, Itoh Y, Nakamura M, Fuchino H, et al. 2016. Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3. Nat Commun. 7:10959.
   PubMed Web of Science ®Google Scholar
• Yee CS, Xie L, Hatsell S, Hum N, Murugesh D, Economides AN, Loots GG, Collette NM. 2016. Sclerostin antibody treatment improves fracture outcomes in a type I diabetic mouse model. Bone. 82:122–134.
   PubMed Web of Science ®Google Scholar
• Ying X, Chen X, Wang T, Zheng W, Chen L, Xu Y. 2020. Possible osteoprotective effects of myricetin in STZ induced diabetic osteoporosis in rats. Eur J Pharmacol. 866:172805.
   PubMed Web of Science ®Google Scholar
• Zheng HX, Chen J, Zu YX, Wang EZ, Qi SS. 2020. Chondroitin sulfate prevents STZ induced diabetic osteoporosis through decreasing blood glucose, antioxidative stress, anti-inflammation and OPG/RANKL expression regulation. Int J Mol Sci. 21:5303.
   PubMed Web of Science ®Google Scholar
• Zheng ZG, Zhang X, Zhou YP, Lu C, Thu PM, Qian C, Zhang M, Li P, Li HJ, Xu X. 2017. Anhydroicaritin, a SREBPs inhibitor, inhibits RANKL-induced osteoclastic differentiation and improves diabetic osteoporosis in STZ-induced mice. Eur J Pharmacol. 809:156–162.
   PubMed Web of Science ®Google Scholar
• Zhou J, Li X, Liao Y, Feng W, Fu C, Guo X. 2015. Pulsed electromagnetic fields inhibit bone loss in streptozotocin-induced diabetic rats. Endocrine. 49(1):258–266.
   PubMed Web of Science ®Google Scholar
• Zhukouskaya VV, Eller-Vainicher C, Shepelkevich AP, Dydyshko Y, Cairoli E, Chiodini I. 2015. Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice. J Endocrinol Invest. 38(9):941–950.
   PubMed Web of Science ®Google Scholar